Stock listing
Dimerix Limited
Selected listing: DXB · ASX · AUD · AU
Dimerix Limited (ASX:DXB), Health Technology. Latest release Oct 4, 2026: First Patient Reaches Four Years in DMX-200 Clinical Program.
- Ticker
- ASX:DXB
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- ASX
- Currency
- AUD
About Dimerix Limited
The company focuses on developing innovative therapies for unmet medical needs. Dimerix is committed to advancing its clinical programs and expanding its presence in the pharmaceutical industry.
Latest news from Dimerix Limited
First Patient Reaches Four Years in DMX-200 Clinical Program
October 4, 2026
Dimerix Draws Down A$17M Under Non-Dilutive Funding Facility
September 22, 2026
Dimerix DMX-652 Granted Mexican Composition of Matter Patent
September 13, 2026
S&P DJI Announces September 2026 Quarterly Rebalance
September 4, 2026
DIMERIX SECURES A$34 MILLION NON-DILUTIVE FACILITY TO FUND KEY CLINICAL MILESTONES
September 3, 2026